| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
169,410,000 |
| Market
Cap: |
97.83(M) |
| Last
Volume: |
3,856,623 |
Avg
Vol: |
3,846,095 |
| 52
Week Range: |
$0.35 - $0.885 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
37,076 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,923 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
5 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kim Jong Joseph |
Chief Executive Officer |
• • • |
2012-05-10 |
4 |
B |
$0.48 |
$24,000 |
D/D |
50,000 |
11,900,809 |
3.15 |
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • • |
2012-03-22 |
4 |
B |
$0.62 |
$11,823 |
D/D |
19,116 |
11,850,809 |
3.15 |
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • • |
2012-03-21 |
4 |
B |
$0.62 |
$19,055 |
D/D |
30,884 |
11,831,693 |
3.15 |
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • • |
2012-03-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
136,800 |
84,130 |
|
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • • |
2012-03-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
136,800 |
11,800,809 |
|
- |
|
| Sardesai Niranjan |
Chief Operating OfficerOfficer |
• – – |
2012-01-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,800 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-13 |
4 |
S |
$0.38 |
$204,584 |
I/I |
(535,000) |
9,828,250 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-12 |
4 |
S |
$0.39 |
$139,248 |
I/I |
(360,000) |
10,363,250 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-09 |
4 |
S |
$0.40 |
$158,120 |
I/I |
(400,000) |
10,723,250 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-06 |
4 |
S |
$0.41 |
$103,500 |
I/I |
(250,000) |
11,926,250 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-05 |
4 |
S |
$0.44 |
$19,888 |
I/I |
(45,200) |
12,176,250 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-02 |
4 |
S |
$0.42 |
$179,563 |
I/I |
(420,000) |
12,221,450 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-12-01 |
4 |
S |
$0.43 |
$530,469 |
I/I |
(1,240,000) |
12,641,450 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-18 |
4 |
S |
$0.60 |
$900 |
I/I |
(1,500) |
13,881,450 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-17 |
4 |
S |
$0.62 |
$1,736 |
I/I |
(2,800) |
13,882,950 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-12 |
4 |
S |
$0.60 |
$12,016 |
I/I |
(19,950) |
13,885,750 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-11 |
4 |
S |
$0.60 |
$5,383 |
I/I |
(8,900) |
13,905,700 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-07 |
4 |
S |
$0.62 |
$14,570 |
I/I |
(23,500) |
13,914,600 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-10-06 |
4 |
S |
$0.60 |
$120,000 |
I/I |
(200,000) |
13,914,600 |
|
- |
|
| Kies Peter |
CFO |
• – – |
2011-10-05 |
4 |
B |
$0.54 |
$9,630 |
I/I |
18,000 |
18,000 |
1.99 |
- |
|
| Kies Peter |
CFO |
• – – |
2011-10-04 |
4 |
B |
$0.50 |
$9,604 |
D/D |
19,150 |
44,712 |
2.74 |
- |
|
| Kim Jong Joseph |
Chief Executive Officer |
• • • |
2011-09-30 |
4 |
B |
$0.56 |
$14,000 |
D/D |
25,000 |
11,937,609 |
3.15 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-09-30 |
4 |
S |
$0.57 |
$113,300 |
I/I |
(200,000) |
14,138,100 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-09-29 |
4 |
S |
$0.57 |
$228,560 |
I/I |
(400,000) |
14,338,100 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2011-09-28 |
4 |
S |
$0.58 |
$124,971 |
I/I |
(213,300) |
14,738,100 |
|
- |
|
505 Records found
|
|
Page 18 of 21 |
|
|
